Reading International (RDI) director awarded 102,941 stock options
Rhea-AI Filing Summary
Reading International Inc. director Douglas McEachern reported an equity award related to his board service. On December 4, 2025, he received stock options for 102,941 shares of Class A Non-Voting Common Stock at an exercise price of $1.29 per share under the company’s 2020 Stock Incentive Plan. These options vest in full on the earlier of December 3, 2026 at 11:59 p.m. Pacific time or the end of his director term when a succeeding board is elected at the next annual or special meeting of stockholders. Following this grant, he is shown as directly owning 68,005 Class A Non-Voting Common shares and 102,941 stock options.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Reading International (RDI) report in this filing?
The filing reports that director Douglas McEachern received a grant of stock options linked to Reading International Inc. Class A Non-Voting Common Stock.
How many Reading International (RDI) stock options were granted and at what exercise price?
Douglas McEachern was granted 102,941 stock options for Class A Non-Voting Common Stock at an exercise price of $1.29 per share.
When do the new Reading International (RDI) director stock options vest?
The options vest in full on the first to occur of 11:59 p.m. Pacific time on December 3, 2026, or the expiration of his director term when the succeeding board is elected at the next annual or special stockholder meeting.
How many Reading International (RDI) Class A shares does the director own after this report?
After the reported transaction, Douglas McEachern is listed as directly owning 68,005 shares of Reading International Inc. Class A Non-Voting Common Stock.
Under which plan were the Reading International (RDI) stock options granted?
The stock options were granted on December 4, 2025 under Reading International Inc.’s 2020 Stock Incentive Plan.
What is the expiration date of the Reading International (RDI) stock options granted to the director?
The granted stock options expire on December 3, 2035, if not exercised earlier.